The American Academy of Pediatrics has warned against using leucovorin to treat autism, citing a lack of evidence on its safety and efficacy.
Despite soaring demand for leucovorin among parents of children with autism spectrum disorder (ASD), the American Academy of Pediatrics (AAP) states that there is "limited evidence" for its safety and effectiveness.
This warning comes after President Trump suggested that leucovorin could be a treatment for speech-related deficits associated with autism, sparking increased interest in the drug.
President Trump also linked autism to childhood vaccinations and the painkiller acetaminophen in a press conference last month.
The FDA has initiated the approval of leucovorin calcium tablets for cerebral folate deficiency (CFD), which causes autism-like symptoms.
Autor's summary: Medicine group warns against leucovorin for autism treatment.